Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

KISMET ACQUISITION TWO CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)

02/23/2021 | 05:24pm EST

Item 1.01. Entry into a Material Definitive Agreement.

On February 17, 2021, the registration statement on Form S-1 (File No. 333-252419) (the "Registration Statement") relating to the initial public offering (the "IPO") of Kismet Acquisition Two Corp. (the "Company") was declared effective by the U.S. Securities and Exchange Commission, and on February 22, 2021, the Company consummated the IPO of 23,000,000 units ("Units"), which included the full exercise of the underwriters' option to purchase additional units. Each Unit consists of one Class A ordinary share of the Company, par value $0.001 per share ("Class A Ordinary Shares"), and one-third of one warrant of the Company ("Warrant"), each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per share, subject to adjustment. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $230,000,000.

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement:

? An Underwriting Agreement, dated February 17, 2021, among the Company and

Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and BofA

Securities, Inc., as representatives of the several underwriters named therein,

a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by

   reference;



? A Warrant Agreement, dated February 17, 2021, between the Company and

Continental Stock Transfer & Trust Company ("Continental"), as warrant agent, a

copy of which is attached as Exhibit 4.1 hereto and incorporated herein by

   reference;



? An Investment Management Trust Agreement, dated February 17, 2021, between the

Company and Continental, as trustee, a copy of which is attached as Exhibit

10.1 hereto and incorporated herein by reference;

? A Private Placement Warrants Purchase Agreement, dated February 17, 2021,

between the Company and Kismet Sponsor Limited (the "Sponsor"), a copy of which

is attached as Exhibit 10.2 hereto and incorporated herein by reference;

? A Registration Rights Agreement, dated February 17, 2021, between the Company

and the Sponsor, a copy of which is attached as Exhibit 10.3 hereto and

incorporated herein by reference;

? A Forward Purchase Agreement, dated February 17, 2021, between the Company and

the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and

incorporated herein by reference;

? An Administrative Services Agreement, dated February 17, 2021, between the

Company and Kismet Capital Group LLC, a copy of which is attached as Exhibit

10.5 hereto and incorporated herein by reference;

? A Letter Agreement, dated February 17, 2021, between the Company and the

Sponsor, a copy of which is attached as Exhibit 10.6 hereto and incorporated

   herein by reference;



? A Letter Agreement, dated February 17, 2021, between the Company and each

officer and director of the Company, a copy of which is attached as Exhibit

10.7 hereto and incorporated herein by reference; and

? Indemnity Agreements, each dated February 17, 2021, between the Company and

each officer and director of the Company, the form of which is attached as

Exhibit 10.8 hereto and incorporated herein by reference.




                                       1

Item 3.02. Unregistered Sales of Equity Securities.

On February 22, 2021, simultaneously with the consummation of the IPO, the Company consummated the private placement of an aggregate of 4,400,000 warrants (the "Private Placement Warrants") to the Sponsor at a price of $1.50 per Private Placement Warrant, generating gross proceeds of $6,600,000 (the "Private Placement"). No underwriting discounts or commissions were paid with respect to the Private Placement. The Private Placement was conducted as a non-public transaction and, as a transaction by an issuer not involving a public offering, is exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act. The Private Placement Warrants are identical to the Warrants underlying the Units, except that if held by the Sponsor or its permitted transferees, they (i) may be exercised on a cashless basis and (ii) are not subject to redemption. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, then the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Warrants included in the Units sold in the IPO. In addition, the Private Placement Warrants (and the Class A Ordinary Shares issuable upon exercise of such Private Placement Warrants) will, subject to certain limited exceptions, be subject to transfer restrictions until 30 days after the completion of the Company's initial business combination.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective as of February 17, 2021, the following individuals were appointed to the board of directors of the Company: Verdi Israelyan, Clifford Tompsett and Leonid Zilber. Additional information regarding, among other things, each individual's background, board committee membership and compensatory arrangements is contained in the Registration Statement and is incorporated herein by reference.



Item 8.01. Other Events.



On February 5, 2021, the Company filed its amended and restated memorandum and articles of association (the "M&A") with the Registrar of Companies in the Cayman Islands. Among other things, the M&A authorizes the issuance of up to 200,000,000 Class A Ordinary Shares and up to 10,000,000 Class B ordinary shares, par value $0.001 per share. The terms of the M&A are set forth in the Registration Statement and are incorporated herein by reference. The foregoing description of the M&A is qualified in its entirety by reference to the full text of the M&A, which is attached as Exhibit 3.1 hereto and is incorporated by reference herein.

A total of $230,000,000 of the net proceeds from the IPO and the Private Placement was placed in a trust account established for the benefit of the Company's public shareholders (the "Trust Account"), with Continental acting as trustee. Except with respect to interest earned on the funds held in the Trust Account that may be released to us to pay our taxes, if any, the funds held in the Trust Account will not be released from the Trust Account until the earliest to occur of: (a) the completion of our initial business combination, (b) the redemption of all of our Class A Ordinary Shares included in the Units sold in the IPO ("public shares") if we are unable to complete our initial business combination within 24 months from the closing of the IPO, subject to applicable law, and (c) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of the IPO or (B) with respect to any other provision relating to shareholders' rights or pre-initial business combination activity.

On February 17, 2021, the Company issued a press release announcing the pricing of the IPO, and on February 22, 2021, the Company issued a press release announcing the closing of the IPO, copies of which are attached as Exhibits 99.1 and 99.2 hereto and incorporated herein by reference.



                                       2

Item 9.01. Financial Statements and Exhibits.




 (d) Exhibits.




Exhibit No.   Description
1.1             Underwriting Agreement, dated February 17, 2021, among the Company
              and Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC
              and BofA Securities, Inc.
3.1             Amended and Restated Memorandum and Articles of Association of the
              Company, dated February 5, 2021.
4.1             Warrant Agreement, dated February 17, 2021, between the Company and
              Continental Stock Transfer & Trust Company.
10.1            Investment Management Trust Agreement, dated February 17, 2021,
              between the Company and Continental Stock Transfer & Trust Company.
10.2            Private Placement Warrants Purchase Agreement, dated February 17,
              2021, between the Company and Kismet Sponsor Limited.
10.3            Registration Rights Agreement, dated February 17, 2021, between the
              Company and Kismet Sponsor Limited.
10.4            Forward Purchase Agreement, dated February 17, 2021, between the
              Company and Kismet Sponsor Limited.
10.5            Administrative Services Agreement, dated February 17, 2021, between
              the Company and Kismet Capital Group LLC.
10.6            Letter Agreement, dated February 17, 2021, between the Company and
              Kismet Sponsor Limited.
10.7            Letter Agreement, dated February 17, 2021, between the Company and
              each officer and director of the Company.
10.8            Form of Indemnity Agreement.
99.1            Press Release, dated February 17, 2021.
99.2            Press Release, dated February 22, 2021.




                                       3

© Edgar Online, source Glimpses

Latest news "Companies"
02:10aCATHAY PACIFIC AIRWAYS : delivers first Fosun Pharma/BioNTech vaccines to Hong Kong and beyond
PU
02:01aBERGENBIO (BGBIO) : AXLeration of data catalysts in 2021
DJ
01:48aSHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Reinvent Technology Partners - RTP
PR
01:44aSHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Pandion Therapeutics, Inc. - PAND
PR
01:39aSHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Protective Insurance Corp. - PTVCA
PR
01:27aASIA TODAY : S. Korea allows workers to squeeze extra doses
AQ
01:04aSHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Cooper Tire & Rubber Company - CTB
PR
01:02aSHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of PRA Health Sciences, Inc. - PRAH
PR
12:50aMcDonald's considers selling part of digital startup Dynamic Yield
RE
12:27aCANSINO BIOLOGICS : CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine in China
PU
Latest news "Companies"